Concord Medical Services (NYSE:CCM) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Concord Medical Services Holdings Limited (NYSE:CCM) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.23 and traded as high as $4.67. Concord Medical Services shares last traded at $4.39, with a volume of 19,609 shares.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a research report on Tuesday, May 26th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Concord Medical Services Stock Performance

The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33. The company has a fifty day simple moving average of $4.72 and a two-hundred day simple moving average of $4.23.

Concord Medical Services (NYSE:CCM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) earnings per share (EPS) for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.